Clinical Trials for Bio-Path Holdings

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Bio-Path Holdings

Clinical Trials (4)

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

PHASE1Recruiting

50 participants

Started: Aug 19, 2022 · Completed: Oct 31, 2027

6 conditions1 sponsor4 locations

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

PHASE1Recruiting

48 participants

Started: Aug 16, 2022 · Completed: Sep 30, 2027

2 conditions1 sponsor4 locations

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

PHASE1Active, not recruiting

30 participants

Started: Nov 5, 2020 · Completed: Apr 30, 2025

10 conditions1 sponsor5 locations

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

PHASE2Recruiting

108 participants

Started: May 31, 2016 · Completed: Dec 31, 2028

1 condition1 sponsor9 locations